Literature DB >> 6283160

Transfer of mouse anti-xenotropic virus neutralizing factor to human lipoproteins.

J A Levy, J Dimpfl, D Hardman, J P Kane.   

Abstract

We examined the migratory properties of the mouse serum protein responsible for specific neutralization of the endogenous mouse xenotropic type C virus and demonstrated that this neutralizing factor can be transferred from mouse lipoproteins to human and to nonreactive mouse lipoproteins. After acceptance of this activity by these lipoproteins, it could be back-transferred to human and to mouse lipoproteins. This result was compatible with equilibrium binding of the responsible proteins by several classes of lipoproteins. The best expression of the transferred activity occurred with human chylomicrons. Small quantities of neutralizing factor which exist in free dispersion in serum were also detected by mixing the p greater than 1.21 g/ml density fraction of mouse serum with human chylomicrons; antiviral activity was subsequently found associated with the human lipoproteins. This result reflects the potentiation of antiviral activity of the protein in a lipoprotein environment. These observations offer a useful approach for the eventual purification and characterization of the neutralizing factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283160      PMCID: PMC256861     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins.

Authors:  J C Leong; J P Kane; O Oleszko; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera.

Authors:  J A Levy; J N Ihle; O Oleszko; R D Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Relationship of endogenous murine xenotropic type C virus production to spontaneous transformation of cultured cells.

Authors:  R J Avery; J A Levy
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

Review 4.  Autoimmunity and neoplasia. The possible role of C-type viruses.

Authors:  J A Levy
Journal:  Am J Clin Pathol       Date:  1974-08       Impact factor: 2.493

5.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

Authors:  R J Havel; J P Kane; M L Kashyap
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum.

Authors:  J P Kane; D A Hardman; J C Dimpfl; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Apoprotein composition of very low density lipoproteins of human serum.

Authors:  J P Kane; T Sata; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice.

Authors:  J A Levy; P Kazan; O Varnier; H Kleiman
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

10.  Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains.

Authors:  J A Levy
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

View more
  2 in total

1.  Genetic control of a mouse serum lipoprotein factor that inactivates murine leukemia viruses: evaluation of apolipoprotein F as a candidate.

Authors:  Tiyun Wu; Chun G Lee; Alicia Buckler-White; Christine A Kozak
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses.

Authors:  M Marin; C S Tailor; A Nouri; S L Kozak; D Kabat
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.